-
公开(公告)号:US06291460B1
公开(公告)日:2001-09-18
申请号:US09582598
申请日:2000-06-28
IPC分类号: C07D48704
CPC分类号: C07D487/04
摘要: 1,2,4-triazolo[4,3-b]pyridazine derivatives, represented by wherein Z represents cyclobutyl, 1-methylcyclopentyl or pyrrolidin-1-yl, are selective ligands for GABAA receptors, in particular having high affinity for the &agr;2 and/or &agr;3 subunit thereof, are useful in the treatment of anxiety and convulsions.
摘要翻译: 由Z代表的1,2,4-三唑并[4,3-b]哒嗪衍生物代表环丁基,1-甲基环戊基或吡咯烷-1-基,是GABA A受体的选择性配体,特别是对α2和/ 或α3亚基可用于治疗焦虑和惊厥。
-
2.
公开(公告)号:US06200982B1
公开(公告)日:2001-03-13
申请号:US09423178
申请日:2000-02-11
申请人: Ian James Collins , Stephen Robert Fletcher , Timothy Harrison , Paul David Leeson , Christopher Richard Moyes , Alan John Nadin , Michael Rowley , Timothy Jason Sparey , Martin Richard Teall
发明人: Ian James Collins , Stephen Robert Fletcher , Timothy Harrison , Paul David Leeson , Christopher Richard Moyes , Alan John Nadin , Michael Rowley , Timothy Jason Sparey , Martin Richard Teall
IPC分类号: A61K31435
CPC分类号: C07D213/64 , C07D401/04 , C07D401/14 , C07D409/14 , C07D413/14 , C07D417/04 , C07D417/14
摘要: Substituted 1H-Pyridinyl-2-ones are useful as GABAA-Alpha 2/3 ligands.
摘要翻译: 取代的1H-吡啶基-2-酮可用作GABAA-α2/3配体
-
公开(公告)号:US07365196B2
公开(公告)日:2008-04-29
申请号:US10239233
申请日:2001-03-15
申请人: Patrice Charles Belanger , Ian James Collins , Joanne Claire Hannam , Timothy Harrison , Stephen John Lewis , Andrew Madin , Edward Giles McIver , Alan John Nadin , Joseph George Neduvelil , Mark Steven Shearman , Adrian Leonard Smith , Timothy Jason Sparey , Graeme Irvine Stevenson , Martin Richard Teall
发明人: Patrice Charles Belanger , Ian James Collins , Joanne Claire Hannam , Timothy Harrison , Stephen John Lewis , Andrew Madin , Edward Giles McIver , Alan John Nadin , Joseph George Neduvelil , Mark Steven Shearman , Adrian Leonard Smith , Timothy Jason Sparey , Graeme Irvine Stevenson , Martin Richard Teall
IPC分类号: C07D413/14 , C07D413/12 , C07D213/71 , C07D213/52 , C07D333/34 , C07D409/14 , C07D409/12 , C07D249/12 , C07D233/84 , C07D207/48 , C07D277/16 , C07D307/64 , A61P25/28
CPC分类号: C07D213/30 , A61K31/18 , A61K31/40 , C07C311/07 , C07C311/09 , C07C311/11 , C07C311/14 , C07C311/20 , C07C311/24 , C07C323/67 , C07C2601/08 , C07C2601/14 , C07C2602/44 , C07C2602/46 , C07C2603/72 , C07C2603/78 , C07D207/36 , C07D211/14 , C07D211/18 , C07D213/71 , C07D213/81 , C07D215/12 , C07D223/32 , C07D231/12 , C07D233/56 , C07D249/08 , C07D271/107 , C07D277/36 , C07D285/14 , C07D285/16 , C07D295/088 , C07D295/135 , C07D295/26 , C07D307/64 , C07D307/81 , C07D319/18 , C07D333/34 , C07D409/12 , C07D413/12 , C07D413/14 , C07D417/04 , C07D417/06 , C07D417/12 , C07D417/14 , C07D487/04 , C07D487/08 , C07D491/08 , C07D491/10 , C07D513/10
摘要: A class of compounds is disclosed, comprising sulphonamido-substituted bridged bicycloalkyl structures. The compounds are inhibitors of gamma-secretase, and hence are useful in the treatment of and/or prevention of Alzheimer's disease.
摘要翻译: 公开了一类化合物,其包含磺酰氨基取代的桥连双环烷基结构。 这些化合物是γ-分泌酶的抑制剂,因此可用于治疗和/或预防阿尔茨海默氏病。
-
公开(公告)号:US07105509B2
公开(公告)日:2006-09-12
申请号:US10296428
申请日:2001-05-21
申请人: Jose Luis Castro Pineiro , Ian Churcher , Alexander Richard Guiblin , Timothy Harrison , Sonia Kerrard , Andrew Madin , Alan John Nadin , Andrew Pate Owens , Timothy Jason Sparey , Martin Richard Teall , Susannah Williams
发明人: Jose Luis Castro Pineiro , Ian Churcher , Alexander Richard Guiblin , Timothy Harrison , Sonia Kerrard , Andrew Madin , Alan John Nadin , Andrew Pate Owens , Timothy Jason Sparey , Martin Richard Teall , Susannah Williams
IPC分类号: C07D243/24 , C07D243/12 , C07D417/04 , A61K31/55 , A61P25/28
CPC分类号: C07D401/04 , A61K31/55 , C07D243/14 , C07D243/24 , C07D401/12 , C07D403/04 , C07D403/12 , C07D405/04 , C07D405/14 , C07D409/04 , C07D409/12 , C07D417/06 , C07D417/12 , C07D487/04 , C07D491/10
摘要: A novel class of 1,4- and 1,5-benzodiazepines of formula (I) is disclosed. The compounds modulate the processing of amyloid precursor protein by γ-secretase, and hence find use in the treatment or prevention of conditions associated with the deposition of β-amyloid, such as Alzheimer's disease
摘要翻译: 公开了一类新颖的式(I)的1,4-和1,5-苯并二氮杂。 该化合物通过γ-分泌酶调节淀粉样前体蛋白的加工,因此可用于治疗或预防与β-淀粉样蛋白沉积相关的病症,例如阿尔茨海默病
-
5.
公开(公告)号:US06352994B2
公开(公告)日:2002-03-05
申请号:US09754092
申请日:2001-01-04
申请人: Ian James Collins , Stephen Robert Fletcher , Timothy Harrison , Paul David Leeson , Christopher Richard Moyes , Alan John Nadin , Michael Rowley , Timothy Jason Sparey , Martin Richard Teall
发明人: Ian James Collins , Stephen Robert Fletcher , Timothy Harrison , Paul David Leeson , Christopher Richard Moyes , Alan John Nadin , Michael Rowley , Timothy Jason Sparey , Martin Richard Teall
IPC分类号: A61K31435
CPC分类号: C07D213/64 , C07D401/04 , C07D401/14 , C07D409/14 , C07D413/14 , C07D417/04 , C07D417/14
摘要: Compounds according to Formula (I) or a salt thereof are selective ligands for GABAA receptors useful for treatment of disorders of the central nervous system:
摘要翻译: 根据式(I)的化合物或其盐是用于治疗中枢神经系统疾病的GABA A受体的选择性配体:
-
公开(公告)号:US6071909A
公开(公告)日:2000-06-06
申请号:US341940
申请日:1999-07-20
IPC分类号: C07D235/08 , A61K31/4184 , A61K31/4439 , A61K31/454 , A61K31/5377 , A61K31/541 , A61P25/08 , A61P25/22 , C07D235/06 , C07D401/10 , C07D401/12 , C07D521/00 , A61K31/415 , A61K31/445 , C07D403/10
CPC分类号: C07D235/06 , C07D231/12 , C07D233/56 , C07D249/08 , C07D401/10 , C07D401/12
摘要: The present patent application discloses compounds having formula (I) ##STR1## or a pharmaceutically acceptable salt thereof or an oxide thereof, wherein R.sup.3 is (II), ##STR2## wherein A, B and D each is CH, or one or two of A, B and D is N and the others are CH; R.sub.11 is phenyl, benzimidazolyl, or monocyclic heteroaryl all of which may be substituted one or more times with substituents selected from alkyl, alkoxy, phenyl, halogen, CF.sub.3, amino, nitro, cyano, acyl, acylamino, phenyl and monocyclic heteroaryl; and one of R.sup.6 and R.sup.7 is hydrogen and the other is furanyl or isoxazolyl each of which may be substituted one or more times with substituents selected from halogen, alkyl, alkoxy and phenyl. The compounds are useful for the treatment of various central nervous system disorders such as epilepsy and other convulsive disorders, anxiety, sleep disorders and memory disorders.
摘要翻译: PCT No.PCT / GB98 / 00322 Sec。 371日期1999年7月20日 102(e)日期1999年7月20日PCT提交1998年2月2日PCT公布。 公开号WO98 / 34923 日本1998年8月13日本专利申请公开了具有式(I)的化合物或其药学上可接受的盐或其氧化物,其中R 3为(II),其中A,B和D各自为CH,或A或 ,B和D为N,其余为CH; R11是苯基,苯并咪唑基或单环杂芳基,其全部可以被选自烷基,烷氧基,苯基,卤素,CF 3,氨基,硝基,氰基,酰基,酰氨基,苯基和单环杂芳基的取代基取代一次或多次; 并且R6和R7中的一个是氢,另一个是呋喃基或异恶唑基,其各自可以被选自卤素,烷基,烷氧基和苯基的取代基取代一次或多次。 该化合物可用于治疗各种中枢神经系统疾病如癫痫和其他惊厥性疾病,焦虑症,睡眠障碍和记忆障碍。
-
公开(公告)号:US06319924B1
公开(公告)日:2001-11-20
申请号:US09582590
申请日:2000-06-28
IPC分类号: C07D23700
CPC分类号: C07D487/04
摘要: 1,2,4-triazolo[4,3-b]pyridazine derivatives, represented by wherein Z represents an optionally substituted tetrahydropyridinyl substituent, are selective ligands for GABAA receptors, in particular having high affinity for the &agr;2 and/or &agr;3 subunit thereof, are useful in the treatment of anxiety and convulsions.
摘要翻译: 由Z代表的1,2,4-三唑并[4,3-b]哒嗪衍生物代表任选取代的四氢吡啶基取代基,是GABA A受体的选择性配体,特别是对其α2和/或α3亚基具有高亲和力 用于治疗焦虑和抽搐。
-
公开(公告)号:US07205434B2
公开(公告)日:2007-04-17
申请号:US10484290
申请日:2002-07-31
IPC分类号: C07C303/00 , A61K31/18
CPC分类号: C07D333/34
摘要: There is disclosed a novel class of sulphonamido-substituted bridged bicycloalkyl derivatives comprising a substitute on the bridgehead position. The compounds modulate the production of the β-amyloid precursor protein, and hence are useful in the treatment of Alzheimer's Disease.
摘要翻译: 公开了一种新型磺酰胺取代的桥连双环烷基衍生物,其包含在桥头头位置上的替代物。 该化合物调节β-淀粉样蛋白前体蛋白的产生,因此可用于治疗阿尔茨海默病。
-
公开(公告)号:US07138400B2
公开(公告)日:2006-11-21
申请号:US10415751
申请日:2001-10-29
申请人: Ian James Collins , Joanne Claire Hannam , Timothy Harrison , Stephen John Lewis , Andrew Madin , Timothy Jason Sparey , Brian John Williams
发明人: Ian James Collins , Joanne Claire Hannam , Timothy Harrison , Stephen John Lewis , Andrew Madin , Timothy Jason Sparey , Brian John Williams
IPC分类号: C07D211/18 , C07D285/10 , A61K31/435 , A61K31/433
CPC分类号: C07D249/08 , A61K31/18 , A61K31/40 , C07C307/08 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07C2601/14 , C07C2602/42 , C07C2602/44 , C07C2602/46 , C07C2603/72 , C07C2603/78 , C07D207/36 , C07D211/14 , C07D211/18 , C07D213/30 , C07D213/71 , C07D213/81 , C07D215/12 , C07D223/32 , C07D231/12 , C07D233/56 , C07D271/107 , C07D277/36 , C07D285/14 , C07D285/16 , C07D295/088 , C07D295/135 , C07D295/26 , C07D307/64 , C07D307/81 , C07D319/18 , C07D333/34 , C07D409/12 , C07D413/12 , C07D413/14 , C07D417/04 , C07D417/06 , C07D417/12 , C07D417/14 , C07D487/04 , C07D487/08 , C07D491/08 , C07D491/10 , C07D513/10
摘要: Novel sulfamides of formula (I) are disclosed. The compounds exert an inhibitory action on the processing of APP by gamma-secretase, and are therefore useful in the treatment or prevention of Alzheimer's disease.
摘要翻译: 公开了式(I)的新型磺酰胺。 该化合物通过γ-分泌酶对APP的加工发挥抑制作用,因此可用于治疗或预防阿尔茨海默氏病。
-
-
-
-
-
-
-
-